Conference Proceeding
Clinical and Radiographic Evaluation of Two Newly Pulp Medicaments Used in Primary Molars Pulpotomy
El-Morsy Badran MM1*, Awad SM2 and Shalan HM11Faculty of Dentistry, Pediatric Dentistry and Dental Public Health Department, Mansoura University, Egypt
2Chairman of Pediatric Dentistry and Public Health Department, Mansoura University, Egypt
- *Corresponding Author:
- Badran El-Morsy MM
Faculty of Dentistry
Pediatric Dentistry and Dental Public Health Department
Mansoura University, Egypt
Tel: 002-01228066974
E-mail: mahmoudbadran2010@mans.edu.eg
Received Date: February 10, 2017; Accepted Date: March 15, 2017; Published Date: March 25, 2017
Citation: El-Morsy Badran MM, Awad SM, Shalan HM (2017) Clinical and Radiographic Evaluation of Two Newly Pulp Medicaments Used in Primary Molars Pulpotomy. Pediatr Dent Care 2:135.
Copyright: © 2017 El-Morsy Badran MM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Primary molars pulpotomy is a very common therapy for primary molars with extensive caries. Many agents including formaldehydebased materials, electro surgery, lasers, glutaraldehyde, haemostatic medicaments, zinc oxide eugenol, bone morphogenic protein (BMP), collagen and calcium involving, Dentin Bridge inducing materials have been developed. However, the ideal pulpotomy treatment still needs to be improved, so this research was done.
